[Skip to Content]
[Skip to Content Landing]
Comment & Response
September 6, 2016

Methylphenidate for Attention-Deficit/Hyperactivity Disorder—Reply

Author Affiliations
  • 1Psychiatric Research Unit, Region Zealand, Denmark
  • 2Copenhagen Trial Unit, Copenhagen, Denmark
 

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;316(9):995. doi:10.1001/jama.2016.10300

In Reply Dr Romanos and colleagues suggest that we included 5 trials in our Cochrane review1 that should have been excluded. We disagree. The 4 trials they state used active controls actually used these cointerventions similarly in both groups (ie, the methylphenidate and the control groups). Such trials should be included according to our protocol.1

×